Financial Connections Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,002
Closed -$69K 257
2025
Q2
$69K Hold
1,002
0.03% 89
2025
Q1
$69K Hold
1,002
0.03% 86
2024
Q4
$86K Hold
1,002
0.04% 71
2024
Q3
$119K Sell
1,002
-37
-4% -$4.93K 0.06% 61
2024
Q2
$148K Buy
+1,039
New +$138K 0.08% 57
2024
Q1
Sell
-1,002
Closed -$103K 235
2023
Q4
$103K Buy
+1,002
New +$99.1K 0.07% 74
2023
Q3
Sell
-1,002
Closed -$81K 199
2023
Q2
$81K Hold
1,002
0.05% 90
2023
Q1
$79K Buy
+1,002
New +$71.1K 0.06% 72

Other funds holding NVO

Financial Connections Group's NVO Position: Q3 2025 in Review

Financial Connections Group sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 1,002 shares — an estimated $69K sold.

Financial Connections Group first reported a position in NVO in Q1 2023 and held it in 8 quarters. The position peaked at $148K in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Financial Connections Group reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Financial Connections Group sold 1,002 Novo Nordisk shares in Q3 2025, an estimated $69K.
  • Financial Connections Group first reported a position in Novo Nordisk in Q1 2023 and held it in 8 quarters.
  • Financial Connections Group's Novo Nordisk position peaked at $148K in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Financial Connections Group's 13F filing for Q3 2025, filed 10 Oct 2025.